Sena Ustaömer

Sena Ustaömer

Auto-generated profile, based on publicly available information

Sena Ustaömer

Department of Clinical Pharmacy, Marmara University Faculty of Health Sciences, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Ankara Universitesi Eczacilik Fakultesi Dergisi
Verified
Journal Article
Open access
PDF file
SUSena Ustaömer
Sena Ustaömer
NSNurten Sayar
Nurten Sayar
MSMurat Sünbül
Murat Sünbül
MSMesut Sancar
Mesut Sancar
Objective: This study was conducted to detect and prevent drug-related problems (DRP) and potentially inappropriate medication (PIM) in patients with heart failure (HF) through a medication review service provided by clinical pharmacists and to increase drug prescription rates according to guideline-directed medical therapy (GDMT). Material and Method: In this prospective study, which included observation and intervention periods, medication review services were provided to patients with HF between September 2023 and March 2024 by two clinical pharmacists. DRPs were classified according to Hepler-Strand and PIMs were evaluated according to Beers criteria®. Result and Discussion: A total of 162 DRPs (1.8 per patient) were detected in 90 patients. The most common cause of DRPs was untreated indication (66.05%). In the observation period, no recommendations were offered, whereas in the intervention period, recommendations were offered to cardiologists, and 63.3% of them were implemented. DRPs were prevented and decreased by recommendations from two clinical pharmacists (from 1.76 to 0.64; p < 0.001). The prescription rates of sodium-glucose co-transporter 2 inhibitors and mineralocorticoid receptor antagonists increased (p0.05). Our results provide compelling evidence that clinical pharmacists' assessment of medication use in patients with HF has made a crucial contribution to treatment management aligning treatment management with current guidelines and reducing DRPs.

1 September 2026 in Endocrinology Research and Practice
Verified
Journal Article
Open access
PDF file
SUSena Ustaömer
Sena Ustaömer
MDMefküre Durmuş
Mefküre Durmuş
ÖÜÖzge Üçüncü
Özge Üçüncü
MKMustafa KOCAK
Mustafa KOCAK
Objective: Hypothyroidism requires lifelong levothyroxine (LT4) therapy, yet achieving target thyroid-stimulating hormone (TSH) levels is often hindered by complex drug–food interactions and poor adherence. This study evaluated the impact of clinical pharmacist-led education on LT4 adherence and treatment effectiveness. Methods: This uncontrolled pre–post interventional study was conducted between November 2024 and April 2025 in an endocrinology outpatient clinic. Patients diagnosed with hypothyroidism initiating LT4 therapy were included. Baseline sociodemographic data and medication habits were recorded, and adherence was assessed using the Turkish-validated Medication Adherence Report Scale-5 (MARS-5). Participants received a 10-min structured verbal education session and an informative brochure. After 3 months, a follow-up was conducted via telephone to re-administer MARS-5 and retrieve serum TSH and free thyroxine (fT4) values from hospital records. Results: Among 152 participants (median age 51; 86.2% female), the median MARS-5 score significantly increased from 24.0 (interquartile range (IQR) 22.0-25.0) to 25.0 (IQR 24.0-25.0; P < .001). Median TSH levels significantly decreased from 2.04 (0.80-3.95) to 1.17 (0.39-3.16) mIU/L (P =.002), while fT4 levels remained stable. Notably, the proportion of patients taking LT4 at least 30 min before breakfast improved from 45.7% to 96.7% (P < .001). Conclusion: A brief, structured clinical pharmacist-led intervention significantly improved LT4 adherence and biochemical treatment outcomes. These findings underscore the clinical value of integrating pharmacist-led education and follow-up services into routine outpatient care to optimize long-term management of hypothyroidism. Cite this article as: Ustaömer S, Durmuş M, Üçüncü Ö, Koçak M. Improving levothyroxine adherence and thyroid-stimulating hormone control via structured clinical pharmacist-led education in patients with hypothyroidism. Endocrinol Res Pract. Published online September 1, 2026. doi: 10.5152/erp.2026.26986.

13 August 2026 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
MDMefküre Durmuş
Mefküre Durmuş
BÇBetül Sena Çavdar
Betül Sena Çavdar
İAİBRAHİM ETEM ARICA
İBRAHİM ETEM ARICA
SUSena Ustaömer
Sena Ustaömer
SKsena güzel karahan
sena güzel karahan
SŞSelcen Şenol
Selcen Şenol
Background/aim: Acne vulgaris, affecting over 85% of adolescents, is the most prevalent chronic inflammatory skin disorder. Its management is severity-based, with specific drug selections and combinations according to guidelines. However, adherence to these guidelines and the adequacy of patient counseling remain uncertain in real-world practice. The aim in this study was to evaluate prescribing patterns in acne management, assess compliance with guidelines, and promote awareness among healthcare professionals. Materials and methods: A prospective observational study was conducted in the dermatology outpatient clinic of a tertiary hospital in Türkiye between February and May 2025. Demographic and clinical data were collected, and acne severity was graded according to the Türkiye Dermatology Association (TDA) criteria. Prescriptions were evaluated for guideline concordance with American Dermatology Association (ADA) 2016/2024, National Institute for Health and Care Excellence (NICE) 2021, and TDA 2018. Potential drug–drug interactions and the adequacy of clinical teaching for acne medication were also assessed through a multidisciplinary evaluation. Statistical analyses were performed using descriptive methods, the Kruskal–Wallis test, Pearson’s chi-squared test, and Fisher’s exact test, as appropriate. Results: Oral isotretinoin, topical retinoids, and topical antibiotics were the most frequently prescribed agents. While isotretinoin use was largely appropriate, deviations from guideline recommendations, particularly oral antibiotic monotherapy, were observed. Some drug–drug interactions and limitations in structured patient counseling were also identified. Among the clinical guidelines, adherence was highest to the ADA guidelines, followed by the TDA guidelines. Moreover, the severity of the disease appeared to influence which guideline was followed. Conclusion: Although treatment largely followed severity-based recommendations, gaps in guideline adherence and patient education highlight the need for improved prescribing practices and interprofessional collaboration in acne management.